Manufacturing Industry

LILLY (ELI) & COMPANY - Jury Issues Verdict in Ariad v. LLY.

PR Newswire UK Disclose, May, 2006

 
Jury Issues Verdict in Ariad v. Lilly Patent Infringement Suit 
 
Lilly Strongly Disputes Jury Decision and Expects to Ultimately Prevail 
 
Eli Lilly and Company (NYSE: LLY) today announced that a jury in the U.S. 
District Court of Massachusetts in Boston has issued an initial decision in the 
case of Ariad Pharmaceuticals et al v. Eli Lilly and Company. The federal 
jury's verdict is that U.S. Patent No. 6,410,516, owned by Harvard, the 
Massachusetts Institute of Technology, and the Whitehead Institute and licensed 
to Ariad Pharmaceuticals, is valid and infringed by Lilly's sale of EvistaA' and 
XigrisA'. 
 
"In my more than thirty years of experience in patent law, which includes 
involvement in dozens of patent lawsuits, I've never seen a jury verdict with 
which I so...

            
        
    
    	    
                
                
	
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here